Murphy & Mullick Capital Management Corp Astrazeneca PLC Transaction History
Murphy & Mullick Capital Management Corp
- $103 Billion
- Q1 2025
A detailed history of Murphy & Mullick Capital Management Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 3,974 shares of AZN stock, worth $294,354. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,974
Previous 4,059
2.09%
Holding current value
$294,354
Previous $266 Million
9.83%
% of portfolio
0.28%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
509MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.23 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.05 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.32 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...